MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2018 International Congress

    Clinical differences between Parkinson’s disease motor phenotypes. Results from the COPPADIS Study Cohort

    I. Legarda Ramirez, B. Vives Pastor, M. Menéndez González, M. Blázquez Estrada, M. Seijo, M. Lage Castro, R. Vázquez Gómez, J. Ruíz Martínez, A. Bergareche Yarza, C. Valero, MM. Kurtis, JR. Pérez Sánchez, O. de Fábregues-Boixar, J. González Ardura, C. Prieto, C. Ordás Bandera, P. Mir, P. Martínez Martín, D. Santos García (Palma de Mallorca, Spain)

    Objective: To describe the prevalence of different motor phenotypes in a large cohort of Parkinson´s disease (PD) patients and to analyze their clinical features in…
  • 2018 International Congress

    Effect of dual task as rehabilitation therapy in Parkinson’s disease in the UPDRS III

    C. Mejia (Lima, Peru)

    Objective: To determine the effect of the dual task used as Rehabilitation therapy in the UPDRS III of patients with Parkinson's disease. Background: Parkinson's disease…
  • 2018 International Congress

    The impact of APOε4 polymorphisms and mutations in the GBA gene on the clinical features of Dementia with Lewy Bodies among Ashkenazi Jews

    T. Shiner, A. Mirelman, Y. Rozenblum, G. Kave', M. Gana Weisz, A. Bar-Shira, A. Thaler, T. Gurevich, A. Orr-Urtreger, N. Gilad, N. Bregman (Tel Aviv, Israel)

    Objective: We aimed to explore the frequency and clinical impact of APOε4 polymorphisms in a cohort of Ashkenazi Jewish (AJ) patients with Dementia with Lewy…
  • 2018 International Congress

    Effect of Glucocerebrosidase enzymatic activity on neural activation during a cognitive task in Parkinson’s disease patients

    M. Ramezani, J.S. Provost, N. Auclair-Ouellet, I. Kathol, A. Hanganu, M. Kibreab, J. Cheetham, T. Hammer, L. Derwent, A. Robichaud, R. Chiang, J. Sarna, SP. Sardi, O. Monchi (Calgary, AB, Canada)

    Objective: To explore the potential correlation of blood Glucocerebrosidase (GCase) enzymatic activity with fMRI brain activity during Wisconsin Card Sorting Task (WCST), while assessing cognitive…
  • 2018 International Congress

    Performance of Parkinson´s disease cognitive scale rating scale (PD-CRS) after subthalamic nucleus deep brain stimulation. Comparison with Mattis Dementia Rating Scale (MDRS) and Mini-Mental State Examination (MMSE)

    C. García-Sánchez, B. Pascual-Sedano, A. Gironell, R. Rodriguez, J. Pagonabarraga-Mora, J. Marin-Lahoz, J. Pérez-Perez, A. Campolongo, C. izquierdo, H. Bejr-Kasen, I. Aracil, S. Martínez -Horta, A. Horta, M. Botí, E. Marin, J. Kulisevsky (Barcelona, Spain)

    Objective: To study the performance of PD-CRS before and after STN-DBS and compare their results with other recognized cognitive scales. Background: Deep brain stimulation of…
  • 2018 International Congress

    Brain Mechanisms of Associative Memory Deficits in Parkinson’s Disease without Dementia

    T. Alrazi, J. Cheetham, L. Derwent, A. Hanganu, T. Hammer, I. Kathol, M. Kibreab, S. Lang, N. Ouellet, J. Provost, M. Ramezani, J. Sarna, E. Yoon, O. Monchi (Calgary, AB, Canada)

    Objective: Characterization of neural mechanisms of associative memory deficits in Parkinson’s disease (PD) without dementia (PD-non-Dementia). Background: The early presence of memory deficits in PD…
  • 2018 International Congress

    PTRHD1 loss-of-function mutation in an African family with parkinsonism and intellectual disability

    IJcken, M. van Slegtenhorst, V. Bonifati (Rotterdam, Netherlands)

    Objective: To investigate the clinical features and identify the disease-causing gene in a black South African family affected by juvenile-onset parkinsonism and intellectual disability. Background:…
  • 2018 International Congress

    Levodopa and subthalamic stimulation do not have the same effect on subjective cost for distal and axial efforts in Parkinson’s disease

    C. Atkinson-Clement, E. Cavazzini, C. Baunez, A. Zénon, S. Pinto, F. Fluchère, E. Robin, T. Witjas, JP. Azulay, A. Eusebio (Aix-en-Provence, France)

    Objective: To compare the effects of levodopa and subthalamic nucleus stimulation (STN-DBS) on decision-making tasks for distal (hand) and axial (speech) efforts in Parkinson’s disease…
  • 2018 International Congress

    It takes two to tango but following may be more beneficial for rehabilitating people with mild-moderate Parkinson’s

    M. Hackney, A. Hart, C. Kim (Atlanta, GA, USA)

    Objective: This study determined the efficacy of internally guided (leading) versus externally guided (following) in adapted tango versus a contact-matched control group (wellness education) for…
  • 2018 International Congress

    Cognitive impairment in multiple system atrophy: A Nepalese tertiary center study

    R. Ojha, K. Oli (Kathmandu, Nepal)

    Objective: This study was done to describe the clinical profile of MSA and evaluate the cognitive function using mini-mental state examination(MMSE). Background: Multiple system atrophy…
  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley